01:09 , Jan 4, 2019 |  BC Week In Review  |  Company News

Lee's subsidiary gets Chinese rights to Auransa's cardioprotective agent

China Oncology Focus Ltd. received exclusive Chinese rights to preclinical candidate AU018 from AI company Auransa Inc. (Palo Alto, Calif.). China Oncology Focus also gained rights to AU018 in other undisclosed countries in Southeast Asia....
20:56 , Jan 3, 2019 |  BC Innovations  |  Emerging Company Profile

Auransa’s AI-predicted pipeline

Auransa Inc. has built a predictive AI-based discovery engine that analyzes patient-derived data to identify and develop the right compound for each patient subpopulation in less time than traditional discovery methods. “The engine unbiasedly reveals...